Overview of Biologically Active Nucleoside Phosphonates
Open Access
- 8 January 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 8
Abstract
The use of the phosphonate motif featuring a carbon-phosphorous bond as bioisosteric replacement of the labile P–O bond is widely recognized as an attractive structural concept in different areas of medicinal chemistry, since it addresses the very fundamental principles of enzymatic stability and minimized metabolic activation. This review discusses the most influential successes in drug design with special emphasis on nucleoside phosphonates and their prodrugs as antiviral and cancer treatment agents. A description of structurally related analogs able to interfere with the transmission of other infectious diseases caused by pathogens like bacteria and parasites will then follow. Finally, molecules acting as agonists/antagonists of P2X and P2Y receptors along with nucleotidase inhibitors will also be covered. This review aims to guide readers through the fundamentals of nucleoside phosphonate therapeutics in order to inspire the future design of molecules to target infections that are refractory to currently available therapeutic options.Keywords
This publication has 187 references indexed in Scilit:
- Acyclic Immucillin Phosphonates: Second-Generation Inhibitors of Plasmodium falciparum Hypoxanthine- Guanine-Xanthine PhosphoribosyltransferaseChemistry & Biology, 2012
- Synthesis and P2Y2 receptor agonist activities of uridine 5′-phosphonate analoguesBioorganic & Medicinal Chemistry, 2012
- Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: Evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine–guanine–(xanthine) phosphoribosyltransferasesBioorganic & Medicinal Chemistry, 2012
- Tyrosine-Based 1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) Prodrugs: Synthesis, Stability, Antiviral Activity, and in Vivo Transport StudiesJournal of Medicinal Chemistry, 2011
- Synthesis, transport and antiviral activity of Ala–Ser and Val–Ser prodrugs of cidofovirBioorganic & Medicinal Chemistry Letters, 2011
- Serine Side Chain-Linked Peptidomimetic Conjugates of Cyclic HPMPC and HPMPA: Synthesis and Interaction with hPEPT1Molecular Pharmaceutics, 2010
- Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester ModificationsJournal of Medicinal Chemistry, 2010
- Human P2Y14Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl GroupsJournal of Medicinal Chemistry, 2009
- Synthesis and P2Y receptor activity of nucleoside 5′-phosphonate derivativesBioorganic & Medicinal Chemistry Letters, 2009
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsBioorganic & Medicinal Chemistry, 2008